カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

世界のラテラルフローアッセイ（LFA）市場（～2029年）：製品別（キット、リーダー）、用途別（STI、新型コロナウィルス感染症、Hep、TB、心臓マーカー、妊娠、薬物乱用、獣医診断、食品）、サンプル別（血液、尿、唾液）、技術別（サンドイッチ、競合）、エンドユーザー別

◆英語タイトル：Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029
	◆商品コード：MD6394-24 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2024年2月 ◆ページ数：383 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥752,400	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥1,010,800	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,238,800	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

“ラテラルフローアッセイ市場は、2023年に推定108億米ドルと評価され、予測期間中にCAGR 7.6%で成長して2029年までに168億米ドルに達すると予測”ラテラルフローアッセイ市場の立ち上がりは、多くの国々における感染症の高い有病率、ポイントオブケア検査に対する需要の高まり、家庭用ラテラルフローアッセイ装置の使用の高まりによるものですが、医師や患者が既存の診断手順を適応させることに臆病であること、ラテラルフローアッセイの精度が低いことが、市場を抑制する要因の一部となっています。

“ラテラルフローアッセイ市場で最も急速にシェアを伸ばしているのはラテラルフローリーダー”
ラテラルフローリーダーは、ラテラルフローアッセイ市場の製品セグメントの一部です。ラテラルフローリーダーは、ラテラルフローアッセイ市場の製品セグメントの一つで、サンドイッチ法、競合法、逆競合法におけるラテラルフローストリップの定量分析を可能にするため、大きなシェアを占めています。ラテラルフローリーダーは、テストラインの強度を測定することで、サンプル中に存在する分析物の数を決定し、完全に定量的なアッセイ結果を得ることができます。ラテラルフローリーダーは、1台の装置で複数の測定値を取得することも、複数の装置で1つの測定値を取得することも可能です。ラテラルフローリーダーは定量、正確なデータ収集、データ転送が可能です。また、非常に高感度です。

“尿サンプルはラテラルフローアッセイ市場で2番目に大きなセグメントを占める見込み”
サンプルタイプ別に見ると、臨床検査用ラテラルフローアッセイ市場は、血液、尿、唾液、その他のサンプルに区分されます。尿サンプルは2022年に第2位の市場シェアを占めました。妊娠検査、不妊検査、薬物乱用検査など、ラテラルフロー検査における尿サンプルの利用が増加していることが、同分野の成長をもたらす要因の1つです。

“予測期間中、アジア太平洋地域が最も高い成長率を記録”
予測期間中、APACは最も速い速度で成長すると予測されています。主な要因は、多くのメーカーが特にアジア太平洋地域で製造を大幅に増やしており、これらの地域では熟練した労働力が利用可能で、低コスト製造の利点を示しているためです。この地域の市場成長を制限している主な要因は、償還不足による近接患者検査製品の利点に関する認識不足、遠隔地に関する課題、識字率の低さです。

本レポートで参照したラテラルフローアッセイ市場の主要参入企業（供給側）の内訳は以下の通り：
- 企業タイプ別企業タイプ別：Tier 1-35%、Tier 2-20%、Tier 3-45%
- 役職別 Cレベル-45%、ディレクターレベル-25%、その他-30%
- 地域別北米-36%、欧州-26%、アジア太平洋-21%、中南米-10%、中東・アフリカ-7%

ラテラルフローアッセイ市場の主要企業としては、Abbott Laboratories（米国）、F. Hoffman-La Roche AG（スイス）、Danaher Corporation（米国）、Siemens AG（ドイツ）、BD（米国）、bioMérieux SA（フランス）、Thermo Fisher Scientific, Inc.（米国）、PerkinElmer Inc.（米国）、Hologic Inc.（米国）、QIAGEN N.V.（オランダ）、Quidel Corporation（米国）、Merck KGaA（ドイツ）などが挙げられます。

調査対象範囲
本調査レポートは、様々なセグメントにわたるラテラルフローアッセイ市場を対象としています。製品別、エンドユーザー別、地域別など、さまざまなセグメントにおける市場規模や成長可能性を推定することを目的としています。また、主要企業の会社概要、製品・事業内容、最近の動向、主要な市場戦略に関する主な見解とともに、市場の主要企業の詳細な競合分析も掲載しています。

レポート購入の理由
本レポートは、ラテラルフローアッセイ市場全体およびサブセグメントにおける収益数の最も近い概算に関する情報を提供し、同市場における市場リーダー/新規参入者に役立ちます。本レポートは、ステークホルダーが競合状況を理解し、より深い洞察を得ることで、事業の位置づけを高め、適切な市場参入戦略を計画するのに役立ちます。また、本レポートは、関係者が市場の鼓動を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供します。

本レポートは、以下のポイントに関する洞察を提供します：
 主な促進要因（感染症の高蔓延、高齢者人口の増加、家庭用ラテラルフローアッセイ装置の使用の増加、ポイントオブケア検査の需要の増加、COVID-19の迅速診断検査の必要性）、阻害要因（ラテラルフロー分析結果の一貫性のなさ）の分析、ラテラルフローアッセイ市場の成長に影響を与える機会（ラテラルフローアッセイのアプリケーションの進化、食品・飲料産業におけるラテラルフローアッセイの需要の高まり）、課題（ラテラルフローアッセイ製品に対する償還の制限、ラテラルフローアッセイ検査開発のための高品質原料の調達難
- 市場への浸透：ラテラルフローアッセイ市場のトップ企業が提供する製品ポートフォリオに関する包括的な情報。製品タイプ、用途、技術、サンプル、エンドユーザー、地域別に市場を分析。
- 製品の強化/革新：ラテラルフローアッセイ市場における今後の動向や製品発売に関する詳細な洞察。
- 市場開発：製品タイプ、アプリケーション、サンプル、技術、エンドユーザー、地域別の有利な新興市場に関する包括的情報。
- 市場の多様化：ラテラルフローアッセイ市場における新製品とサービス、成長地域、最近の開発、投資に関する詳細な情報。
- 競合他社の評価：ラテラルフローアッセイ市場における主要企業の市場シェア、成長戦略、製品・サービス、能力を詳細に評価。

1 はじめに
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 ラテラルフローアッセイ（LFA）市場：製品別
7 ラテラルフローアッセイ（LFA）市場：用途別
8 ラテラルフローアッセイ（LFA）キット＆試薬市場：技術別
9 臨床検査用ラテラルフローアッセイ（LFA）市場：サンプルタイプ別
10 ラテラルフローアッセイ（LFA）市場：エンドユーザー別
11 ラテラルフローアッセイ（LFA）市場：地域別
12 競争状況
13 企業プロファイル
14 付録

❖ レポートの目次 ❖

1 INTRODUCTION 52
1.1 OBJECTIVES OF THE STUDY 52
1.2 MARKET DEFINITION 52
1.2.1 INCLUSIONS AND EXCLUSIONS 52
1.3 MARKET SCOPE 53
1.3.1 MARKETS COVERED 53
FIGURE 1 LATERAL FLOW ASSAYS MARKET SEGMENTATION 53
1.3.2 REGIONS COVERED 54
FIGURE 2 REGIONAL SCOPE 54
1.3.3 YEARS CONSIDERED 54
1.3.4 CURRENCY CONSIDERED 54
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 55
1.4 STAKEHOLDERS 55
1.5 SUMMARY OF CHANGES 55
1.5.1 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH APPROACH 57
FIGURE 3 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 57
2.1.1.1 Key data from secondary sources 58
2.1.2 PRIMARY DATA 59
2.1.2.1 Primary sources 59
2.1.2.2 Key data from primary sources 60
2.1.2.3 Breakdown of primaries 60
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 60
2.2 MARKET SIZE ESTIMATION 61
FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 61
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022) 62
FIGURE 7 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2022) 62
FIGURE 8 APPROACH 3: DEMAND-SIDE APPROACH, BASED ON MALARIA LATERAL FLOW TESTING MARKET SIZE (2022) 63
FIGURE 9 APPROACH 4: TOP-DOWN APPROACH 63
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029): IMPACT ON MARKET GROWTH AND CAGR 65
FIGURE 11 CAGR PROJECTIONS 65
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 66
FIGURE 12 DATA TRIANGULATION METHODOLOGY 66
2.4 KEY INDUSTRY INSIGHTS 67
2.5 LIMITATIONS 67
2.5.1 METHODOLOGY-RELATED LIMITATIONS 67
2.6 RISK ASSESSMENT 68
2.7 STUDY ASSUMPTIONS 68
2.8 RECESSION IMPACT ANALYSIS 69
3 EXECUTIVE SUMMARY 70
FIGURE 13 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2023 VS. 2029 (USD MILLION) 70
FIGURE 14 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2023 VS. 2029 (USD MILLION) 71
FIGURE 15 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION) 71
FIGURE 16 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2023 VS. 2029 (USD MILLION) 72
FIGURE 17 LATERAL FLOW ASSAYS MARKET, BY END USER, 2023 VS. 2029 (USD MILLION) 72
FIGURE 18 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL SNAPSHOT 73
4 PREMIUM INSIGHTS 74
4.1 LATERAL FLOW ASSAYS MARKET OVERVIEW 74
FIGURE 19 HIGH PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET 74
4.2 REGIONAL MIX: LATERAL FLOW ASSAYS MARKET 74
FIGURE 20 ASIA PACIFIC TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD 74
4.3 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION AND COUNTRY (2022) 75
FIGURE 21 CLINICAL TESTING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 75
4.4 LATERAL FLOW ASSAYS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 76
FIGURE 22 CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 76
4.5 LATERAL FLOW ASSAYS MARKET: DEVELOPED COUNTRIES VS. EMERGING ECONOMIES 76
FIGURE 23 EMERGING ECONOMIES TO OFFER HIGH GROWTH OPPORTUNITIES IN FORECAST PERIOD 76
5 MARKET OVERVIEW 77
5.1 INTRODUCTION 77
5.2 MARKET DYNAMICS 77
FIGURE 24 LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 77
5.2.1 DRIVERS 77
5.2.1.1 High prevalence of infectious diseases 77
TABLE 2 PREVALENCE OF HIV WORLDWIDE (2017 VS. 2021) 78
5.2.1.2 Rising geriatric population 78
FIGURE 25 GERIATRIC POPULATION, BY REGION, 2020 VS. 2050 (MILLION) 78
FIGURE 26 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050 (% OF TOTAL POPULATION) 79
5.2.1.3 Growing use of home-based lateral flow assay devices 79
5.2.1.4 Growing demand for POC testing 80
5.2.2 RESTRAINTS 80
5.2.2.1 Inconsistent results of lateral flow assay tests 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 Evolving applications of lateral flow assays 81
TABLE 3 LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS 81
5.2.3.2 Rising demand for lateral flow assays in food & beverage industry 82
5.2.3.3 Emergence of Omicron COVID variant 82
TABLE 4 EPIDEMIOLOGICAL UPDATE ON OMICRON VARIANT 82
TABLE 5 EXAMPLES OF LATERAL FLOW ASSAY KITS AVAILABLE TO DETECT OMICRON 83
5.2.4 CHALLENGES 83
5.2.4.1 Limited reimbursements for lateral flow assay products 83
5.2.4.2 Difficulties in procuring quality raw materials to develop tests 84
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 84
FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 84
5.4 PRICING ANALYSIS 85
5.4.1 AVERAGE SELLING PRICE TREND, BY APPLICATION 85
TABLE 6 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAYS (KITS & REAGENTS), BY COMPANY AND APPLICATION, 2021–2023 85
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 85
TABLE 7 AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION, 2020 VS. 2022 86
5.5 ECOSYSTEM 86
TABLE 8 LATERAL FLOW ASSAYS MARKET: ECOSYSTEM ANALYSIS (2022) 86
5.6 SUPPLY CHAIN ANALYSIS 87
5.6.1 PROMINENT COMPANIES 87
5.6.2 SMALL & MEDIUM-SIZED COMPANIES 87
5.6.3 END USERS 87
5.7 PATENT ANALYSIS 88
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 88
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN LATERAL FLOW ASSAYS MARKET, 2013–2023 88
5.7.2 TOP APPLICANTS (COMPANIES) OF LATERAL FLOW ASSAY PATENTS 89
FIGURE 29 TOP COMPANIES THAT APPLIED FOR LATERAL FLOW ASSAY PATENTS, 2016–2022 89
5.7.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN LATERAL FLOW ASSAYS MARKET 89
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAY PATENTS, 2016–2022 89
5.8 VALUE CHAIN ANALYSIS 90
FIGURE 31 LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2022) 90
5.9 TECHNOLOGY ANALYSIS 90
5.9.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 90
5.9.2 ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS) 91
5.10 CASE STUDY ANALYSIS 91
5.10.1 CASE STUDY 1: QUIDEL LAUNCHES NEW TEST WITH BROADER DETECTION WINDOW 91
5.10.2 CASE STUDY 2: ABINGTON OFFERS HIGH-SENSITIVITY TESTS FOR GREATER QUALITY 91
5.10.3 CASE STUDY 3: SIEMENS OFFERS HIGH-SENSITIVITY TROPONIN I ASSAY TO RAPIDLY DETECT ACUTE MYOCARDIAL INFARCTION 92
5.11 REGULATORY ANALYSIS 92
5.11.1 REGULATORY LANDSCAPE 92
5.11.1.1 North America 92
5.11.1.2 Europe 93
5.11.1.3 Asia 93
5.11.1.3.1 India 93
5.11.1.3.2 China 93
5.11.1.3.3 Japan 93
5.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.11.2.1 North America 94
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.11.2.2 Europe 94
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.11.2.3 Asia Pacific 95
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.11.2.4 Latin America 95
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.11.2.5 Rest of the world 95
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.12 PORTER’S FIVE FORCES ANALYSIS 96
TABLE 14 LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS 96
5.12.1 THREAT OF NEW ENTRANTS 96
5.12.2 THREAT OF SUBSTITUTES 97
5.12.3 BARGAINING POWER OF SUPPLIERS 97
5.12.4 BARGAINING POWER OF BUYERS 97
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 97
5.13 ADJACENT MARKET ANALYSIS 98
FIGURE 32 LATERAL FLOW ASSAYS: OVERVIEW OF ADJACENT MARKETS 98
5.14 KEY CONFERENCES AND EVENTS, 2023–2024 98
TABLE 15 LATERAL FLOW ASSAYS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 98
5.15 TRADE ANALYSIS 99
5.15.1 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS 99
TABLE 16 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION) 99
5.15.2 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS 99
TABLE 17 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION) 99
5.16 INDUSTRY TRENDS 99
5.16.1 DETECTION OF HIV WITH LATERAL FLOW ASSAYS 99
TABLE 18 US: HIV PREVALENCE RATE, 2016–2021 100
5.16.2 INCREASING ADOPTION OF QUANTITATIVE LATERAL FLOW ASSAYS DUE TO AVAILABILITY OF LFA READERS 100
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 101
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 101
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 101
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 101
5.17.2 BUYING CRITERIA 101
FIGURE 34 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 101
5.18 LATERAL FLOW ASSAYS MARKET: IMPACT OF INFLATION AND RECESSION 102
5.19 ARTIFICIAL INTELLIGENCE (AI) IN LATERAL FLOW ASSAY MARKET 102
TABLE 20 POTENTIAL APPLICATIONS OF AI IN LATERAL FLOW ASSAYS 102
5.20 UNMET NEEDS/END-USER EXPECTATIONS 103
TABLE 21 LATERAL FLOW ASSAYS MARKET: UNMET NEEDS/END-USER EXPECTATIONS 103
5.21 INVESTMENT/VENTURE CAPITAL 103
FIGURE 35 LATERAL FLOW ASSAYS MARKET: INVESTMENT/VENTURE CAPITAL SCENARIO, 2018–2022 103
6 LATERAL FLOW ASSAYS MARKET, BY PRODUCT 104
6.1 INTRODUCTION 105
TABLE 22 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 105
6.2 KITS & REAGENTS 105
6.2.1 RISING DEMAND FOR POC TESTING TO DRIVE MARKET 105
TABLE 23 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 106
6.3 READERS 106
TABLE 24 LATERAL FLOW READERS OFFERED, BY COMPANY 107
TABLE 25 INDICATIVE LIST OF LATERAL FLOW ASSAY KITS & REAGENTS: WITH AND WITHOUT ANALYZERS 108
TABLE 26 LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 109
TABLE 27 LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 109
6.3.1 DIGITAL/HANDHELD READERS 110
6.3.1.1 Technological evolutions and accuracy to drive adoption 110
TABLE 28 DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION). 111
6.3.2 BENCHTOP READERS 111
6.3.2.1 Lower diagnosis cost per patient to drive adoption 111
TABLE 29 BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 112
6.3.3 INSIGHTS ON DISPOSABLE AND REUSABLE LATERAL FLOW ASSAY READERS 112
6.3.4 LATERAL FLOW READERS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE 113
TABLE 30 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS 113
FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF LATERAL FLOW READERS FOR CLINICAL DIAGNOSTICS (2022) 114
7 LATERAL FLOW ASSAYS MARKET, BY APPLICATION 115
7.1 INTRODUCTION 116
TABLE 31 LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 116
7.2 CLINICAL TESTING 116
TABLE 32 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 117
TABLE 33 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 118
7.2.1 INFECTIOUS DISEASE TESTING 118
TABLE 34 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 119
TABLE 35 LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 120
7.2.1.1 Mosquito-borne diseases 120
7.2.1.1.1 Increasing incidence of dengue to drive market 120
TABLE 36 MAJOR PRODUCTS: DENGUE TESTING 121
TABLE 37 LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES, BY COUNTRY, 2021–2029 (USD MILLION) 122
7.2.1.2 COVID-19 123
7.2.1.2.1 Demand for testing to drive market for COVID-19 assays 123
FIGURE 37 NORTH MARKET SIZING FOR COVID-19: SCENARIO-BASED FORECASTING 124
TABLE 38 COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS 124
TABLE 39 LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY, 2021–2029 (USD MILLION) 125
7.2.1.3 Influenza 126
7.2.1.3.1 Rising prevalence of influenza globally to boost market growth 126
TABLE 40 LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 2021–2029 (USD MILLION) 127
7.2.1.4 Sexually transmitted infections 127
TABLE 41 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 128
TABLE 42 LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION) 129
7.2.1.4.1 HIV 129
TABLE 43 LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY, 2021–2029 (USD MILLION) 131
7.2.1.4.2 HPV 131
TABLE 44 LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY, 2021–2029 (USD MILLION) 132
7.2.1.4.3 Chlamydia 133
TABLE 45 LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2021–2029 133
7.2.1.4.4 Gonorrhea 134
TABLE 46 LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 2021–2029 (USD MILLION) 135
7.2.1.4.5 Syphilis 135
TABLE 47 LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 2021–2029 (USD MILLION) 136
7.2.1.4.6 Other sexually transmitted infections 137
TABLE 48 LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2021–2029 (USD MILLION) 137
7.2.1.5 Hepatitis 138
7.2.1.5.1 Nucleic acid hybridization-based LFAs to show strong potential in hepatitis testing 138
TABLE 49 LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY, 2021–2029 (USD MILLION) 139
7.2.1.6 Tuberculosis 139
7.2.1.6.1 Rising prevalence and growing focus on early diagnosis and treatment to drive market 139
TABLE 50 LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 2021–2029 (USD MILLION) 140
7.2.1.7 Other infectious diseases 141
TABLE 51 LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES, BY COUNTRY, 2021–2029 (USD MILLION) 142
7.2.2 CARDIAC MARKER TESTING 142
TABLE 52 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 143
TABLE 53 LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 144
7.2.2.1 Troponin I & T 144
7.2.2.1.1 Introduction of high-sensitivity troponin assays to drive market 144
TABLE 54 LATERAL FLOW ASSAYS MARKET FOR TROPONIN I & T TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 145
7.2.2.2 CK-MB 146
7.2.2.2.1 Growing applications of lateral flow tests in acute myocardial injuries to drive market 146
TABLE 55 LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 146
7.2.2.3 BNP & NT-proBNP 147
7.2.2.3.1 Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth 147
TABLE 56 LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 147
7.2.2.4 Myoglobin 148
7.2.2.4.1 Availability of new high-sensitivity cardiac troponin assays to restrict market growth 148
TABLE 57 LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 148
7.2.2.5 D-Dimer 149
7.2.2.5.1 Rising incidence of CVDs to drive market for D-dimer tests 149
TABLE 58 LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 149
7.2.2.6 Other cardiac marker tests 150
TABLE 59 LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS, BY COUNTRY, 2021–2029 (USD MILLION) 151
7.2.3 PREGNANCY & FERTILITY TESTING 152
TABLE 60 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 152
TABLE 61 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 153
7.2.3.1 Pregnancy testing 153
7.2.3.1.1 Pregnancy testing to hold larger market share but register slower growth 153
TABLE 62 LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 154
7.2.3.2 Fertility testing 155
7.2.3.2.1 Rising infertility rates to drive demand for POC fertility testing kits 155
TABLE 63 LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 155
7.2.4 CHOLESTEROL/LIPID TESTING 156
7.2.4.1 Lifestyle changes, rising obesity prevalence to drive market 156
TABLE 64 LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL/LIPID TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 157
7.2.5 DRUGS-OF-ABUSE TESTING 157
7.2.5.1 Technological advancements and rising focus on workplace drug testing to drive market 157
TABLE 65 LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 158
7.2.6 OTHER CLINICAL TESTS 159
TABLE 66 LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY, 2021–2029 (USD MILLION) 159
7.3 VETERINARY DIAGNOSTICS 160
7.3.1 INFECTIOUS DISEASE OUTBREAKS TO DRIVE MARKET 160
TABLE 67 LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS, BY COUNTRY, 2021–2029 (USD MILLION) 161
7.4 FOOD SAFETY & ENVIRONMENT TESTING 161
7.4.1 HIGH SENSITIVITY AND EASE OF USE TO BOOST DEMAND FOR ASSAYS 161
TABLE 68 LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 162
7.5 DRUG DEVELOPMENT & QUALITY TESTING 163
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO SUPPORT MARKET GROWTH 163
TABLE 69 LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING, BY COUNTRY, 2021–2029 (USD MILLION) 164
8 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE 165
8.1 INTRODUCTION 166
TABLE 70 LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 166
8.2 SANDWICH ASSAYS 167
8.2.1 WIDE APPLICATIONS IN CLINICAL TESTING TO SUPPORT MARKET GROWTH 167
TABLE 71 LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 168
8.3 COMPETITIVE ASSAYS 168
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY COMPARED TO SANDWICH ASSAYS TO HAMPER GROWTH 168
TABLE 72 LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 169
8.4 MULTIPLEX DETECTION ASSAYS 170
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET 170
TABLE 73 LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 171
9 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE 172
9.1 INTRODUCTION 173
TABLE 74 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 173
9.2 BLOOD SAMPLES 173
9.2.1 INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE MARKET 173
TABLE 75 LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION) 174
9.3 URINE SAMPLES 174
9.3.1 GROWING USE OF URINE SAMPLES FOR PREGNANCY AND DRUGS-OF-ABUSE TESTING TO DRIVE MARKET 174
TABLE 76 LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION) 175
9.4 SALIVA SAMPLES 176
9.4.1 EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES TO SUPPORT ADOPTION 176
TABLE 77 LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION) 176
9.5 OTHER SAMPLES 177
TABLE 78 LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES, BY COUNTRY, 2021–2029 (USD MILLION) 177
10 LATERAL FLOW ASSAYS MARKET, BY END USER 178
10.1 INTRODUCTION 179
TABLE 79 LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 179
10.2 HOSPITALS & CLINICS 179
10.2.1 INCREASING USE OF POC TESTS TO DRIVE MARKET 179
TABLE 80 LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2029 (USD MILLION) 180
10.3 HOME CARE SETTINGS 180
10.3.1 GROWING ACCEPTANCE OF REMOTE MONITORING TO PROPEL MARKET 180
TABLE 81 LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2029 (USD MILLION) 181
10.4 DIAGNOSTIC LABORATORIES 182
10.4.1 LABORATORY TESTING LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING 182
TABLE 82 LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2029 (USD MILLION) 182
10.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 183
10.5.1 INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE ADOPTION OF LATERAL FLOW ASSAYS 183
TABLE 83 LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2029 (USD MILLION) 183
10.6 OTHER END USERS 184
TABLE 84 LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2029 (USD MILLION) 185
11 LATERAL FLOW ASSAYS MARKET, BY REGION 186
11.1 INTRODUCTION 187
FIGURE 38 CHINA TO WITNESS HIGHEST GROWTH IN FORECAST PERIOD 187
TABLE 85 LATERAL FLOW ASSAYS MARKET, BY REGION, 2021–2029 (USD MILLION) 188
11.2 NORTH AMERICA 188
TABLE 86 NORTH AMERICA: MACROECONOMIC INDICATORS 189
FIGURE 39 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT 189
TABLE 87 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 190
TABLE 88 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 190
TABLE 89 NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 190
TABLE 90 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 191
TABLE 91 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 191
TABLE 92 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 192
TABLE 93 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 192
TABLE 94 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 193
TABLE 95 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 193
TABLE 96 NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 194
TABLE 97 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 194
TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 195
11.2.1 NORTH AMERICA: RECESSION IMPACT 195
11.2.2 US 195
11.2.2.1 US to hold largest market share of global market, by country 195
TABLE 99 US: MACROECONOMIC INDICATORS 196
TABLE 100 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 196
TABLE 101 US: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 197
TABLE 102 US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 197
TABLE 103 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 198
TABLE 104 US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 198
TABLE 105 US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 199
TABLE 106 US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 199
TABLE 107 US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 200
TABLE 108 US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 200
TABLE 109 US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 200
TABLE 110 US: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION) 201
11.2.3 CANADA 201
11.2.3.1 Availability of research funding and implementation of favorable government initiatives to drive market 201
TABLE 111 CANADA: MACROECONOMIC INDICATORS 202
TABLE 112 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 202
TABLE 113 CANADA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 202
TABLE 114 CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 203
TABLE 115 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 203
TABLE 116 CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 204
TABLE 117 CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 204
TABLE 118 CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 205
TABLE 119 CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 205
TABLE 120 CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 206
TABLE 121 CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 206
TABLE 122 CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029USD MILLION) 207

11.3 EUROPE 207
11.3.1 EUROPE: RECESSION IMPACT 207
TABLE 123 EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 208
TABLE 124 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 208
TABLE 125 EUROPE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 208
TABLE 126 EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 209
TABLE 127 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 209
TABLE 128 EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 210
TABLE 129 EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 210
TABLE 130 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 211
TABLE 131 EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 211
TABLE 132 EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 212
TABLE 133 EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 212
TABLE 134 EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 213
11.3.2 GERMANY 213
11.3.2.1 Growing number of POC diagnostics centers to drive demand 213
TABLE 135 GERMANY: MACROECONOMIC INDICATORS 213
TABLE 136 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 214
TABLE 137 GERMANY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 214
TABLE 138 GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 214
TABLE 139 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 215
TABLE 140 GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 215
TABLE 141 GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 216
TABLE 142 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 216
TABLE 143 GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 217
TABLE 144 GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 217
TABLE 145 GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 217
TABLE 146 GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 218
11.3.3 FRANCE 218
11.3.3.1 High prevalence of age-related chronic diseases and infectious diseases to drive market 218
TABLE 147 FRANCE: MACROECONOMIC INDICATORS 218
TABLE 148 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 219
TABLE 149 FRANCE: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 219
TABLE 150 FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 219
TABLE 151 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 220
TABLE 152 FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 220
TABLE 153 FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 221
TABLE 154 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 221
TABLE 155 FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 222
TABLE 156 FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 222
TABLE 157 FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 222
TABLE 158 FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 223
11.3.4 UK 223
11.3.4.1 Rising prevalence of obesity to propel market 223
TABLE 159 UK: MACROECONOMIC INDICATORS 224
TABLE 160 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 224
TABLE 161 UK: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 224
TABLE 162 UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 225
TABLE 163 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 225
TABLE 164 UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 226
TABLE 165 UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 226
TABLE 166 UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 227
TABLE 167 UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 227
TABLE 168 UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 228
TABLE 169 UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 228
TABLE 170 UK: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 229
11.3.5 ITALY 229
11.3.5.1 Growing initiatives toward decentralization of medical services to support market growth 229
TABLE 171 ITALY: MACROECONOMIC INDICATORS 229
TABLE 172 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 230
TABLE 173 ITALY: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 230
TABLE 174 ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 230
TABLE 175 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 231
TABLE 176 ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 231
TABLE 177 ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 232
TABLE 178 ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 232
TABLE 179 ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 233
TABLE 180 ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 233
TABLE 181 ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 233
TABLE 182 ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 234
11.3.6 SPAIN 234
11.3.6.1 Increasing focus of international organizations and domestic players on developing POC products to aid market growth 234
TABLE 183 SPAIN: MACROECONOMIC INDICATORS 234
TABLE 184 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 235
TABLE 185 SPAIN: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 235
TABLE 186 SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 235
TABLE 187 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 236
TABLE 188 SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 236
TABLE 189 SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 237
TABLE 190 SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 237
TABLE 191 SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 238
TABLE 192 SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, B
11.4 ASIA PACIFIC 244
11.4.1 ASIA PACIFIC: RECESSION IMPACT 245
FIGURE 40 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT 245
TABLE 206 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 246
TABLE 207 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 246
TABLE 208 ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 246
TABLE 209 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 247
TABLE 210 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 247
TABLE 211 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 248
TABLE 212 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 248
TABLE 213 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 249
TABLE 214 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 249
TABLE 215 ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 250
TABLE 216 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 250
TABLE 217 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 251
11.4.2 CHINA 251
11.4.2.1 Growing adoption of lateral flow assays in veterinary diagnostics and drug development to drive market 251
TABLE 218 CHINA: MACROECONOMIC INDICATORS 252
TABLE 219 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 252
TABLE 220 CHINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 252
TABLE 221 CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 253
TABLE 222 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 253
TABLE 223 CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 254
TABLE 224 CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 254
TABLE 225 CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 255
TABLE 226 CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 255
TABLE 227 CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 256
TABLE 228 CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 256
TABLE 229 CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 257
11.4.3 JAPAN 257
11.4.3.1 Increasing prevalence of age-related illnesses to drive market 257
TABLE 230 JAPAN: MACROECONOMIC INDICATORS 258
TABLE 231 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 258
TABLE 232 JAPAN: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 258
TABLE 233 JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 259
TABLE 234 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 259
TABLE 235 JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 260
TABLE 236 JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 260
TABLE 237 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 261
TABLE 238 JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 261
TABLE 239 JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 262
TABLE 240 JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 262
TABLE 241 JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 263
11.4.4 INDIA 263
11.4.4.1 Growing healthcare concerns and rising income levels to propel market growth 263
TABLE 242 INDIA: MACROECONOMIC INDICATORS 263
TABLE 243 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 264
TABLE 244 INDIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 264
TABLE 245 INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 264
TABLE 246 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 265
TABLE 247 INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 265
TABLE 248 INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 266
TABLE 249 INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 266
TABLE 250 INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 267
TABLE 251 INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 267
TABLE 252 INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 267
TABLE 253 INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 268
11.4.5 AUSTRALIA 268
11.4.5.1 Increasing prevalence of infectious diseases, especially influenza, to drive market 268
TABLE 254 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 268
TABLE 255 AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 269
TABLE 256 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 269
TABLE 257 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 270
TABLE 258 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 270
TABLE 259 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 271
TABLE 260 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 271
TABLE 261 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 272
TABLE 262 AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 272
TABLE 263 AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 272
TABLE 264 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 273
11.4.6 SOUTH KOREA 273
TABLE 265 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 273
TABLE 266 SOUTH KOREA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 274
TABLE 267 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 274
TABLE 268 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 275
TABLE 269 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 275
TABLE 270 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 276
TABLE 271 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 276
TABLE 272 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 277
TABLE 273 SOUTH KOREA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 277
TABLE 274 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 277
TABLE 275 SOUTH KOREA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 278
11.4.7 REST OF ASIA PACIFIC 278
TABLE 276 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 278
TABLE 277 REST OF ASIA PACIFIC: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 279
TABLE 278 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 279
TABLE 279 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 280
TABLE 280 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 280
TABLE 281 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 281
TABLE 282 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 281
TABLE 283 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 282
TABLE 284 REST OF ASIA PACIFIC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 282
TABLE 285 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 282
TABLE 286 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 283
11.5 LATIN AMERICA 283
11.5.1 LATIN AMERICA: RECESSION IMPACT 283
TABLE 287 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2021–2029 (USD MILLION) 284
TABLE 288 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 284
TABLE 289 LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 284
TABLE 290 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 285
TABLE 291 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 285
TABLE 292 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 286
TABLE 293 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 286
TABLE 294 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 295 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 287
TABLE 296 LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 288
TABLE 297 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 288
TABLE 298 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 289
11.5.2 BRAZIL 289
11.5.2.1 High private healthcare expenditure and rising geriatric population to drive market 289
TABLE 299 BRAZIL: MACROECONOMIC INDICATORS 289
TABLE 300 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 290
TABLE 301 BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 290
TABLE 302 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 290
TABLE 303 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 291
TABLE 304 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 291
TABLE 305 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 292
TABLE 306 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 292
TABLE 307 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 293
TABLE 308 BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 293
TABLE 309 BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 293
TABLE 310 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 294
11.5.3 MEXICO 294
11.5.3.1 High prevalence of obesity and related chronic diseases to propel market 294
TABLE 311 MEXICO: MACROECONOMIC INDICATORS 294
TABLE 312 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 295
TABLE 313 MEXICO: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 295
TABLE 314 MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 295
TABLE 315 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 296
TABLE 316 MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 296
TABLE 317 MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 318 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 297
TABLE 319 MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 298
TABLE 320 MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 298
TABLE 321 MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 298
TABLE 322 MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 299
11.5.4 ARGENTINA 299
11.5.4.1 Availability of health insurance to favor market growth 299
TABLE 323 ARGENTINA: MACROECONOMIC INDICATORS 299
TABLE 324 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 300
TABLE 325 ARGENTINA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 300
TABLE 326 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 300
TABLE 327 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 301
TABLE 328 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 301
TABLE 329 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 330 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 302
TABLE 331 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 303
TABLE 332 ARGENTINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 303
TABLE 333 ARGENTINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 303
TABLE 334 ARGENTINA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 304
11.5.5 REST OF LATIN AMERICA 304
TABLE 335 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 304
TABLE 336 REST OF LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 305
TABLE 337 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 305
TABLE 338 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 306
TABLE 339 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 306
TABLE 340 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 341 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 307
TABLE 342 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 308
TABLE 343 REST OF LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 308
TABLE 344 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 308
TABLE 345 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 309
11.6 MIDDLE EAST & AFRICA 309
11.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TO DRIVE MARKET 309
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 310
TABLE 346 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 310
TABLE 347 MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 310
TABLE 348 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 311
TABLE 349 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 311
TABLE 350 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 312
TABLE 351 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 312
TABLE 352 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 353 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 313
TABLE 354 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 314
TABLE 355 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 314
TABLE 356 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 315
11.6.3 GCC COUNTRIES 315
11.6.3.1 GCC countries: Recession impact 315
TABLE 357 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2021–2029 (USD MILLION) 316
TABLE 358 GCC COUNTRIES: LATERAL FLOW READERS MARKET, BY TYPE, 2021–2029 (USD MILLION) 316
TABLE 359 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 2021–2029 (USD MILLION) 316
TABLE 360 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY TYPE, 2021–2029 (USD MILLION) 317
TABLE 361 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2021–2029 (USD MILLION) 317
TABLE 362 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 363 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2021–2029 (USD MILLION) 318
TABLE 364 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2021–2029 (USD MILLION) 319
TABLE 365 GCC COUNTRIES: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 2021–2029 (USD MILLION) 319
TABLE 366 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING, BY SAMPLE TYPE, 2021–2029 (USD MILLION) 319
TABLE 367 GCC COUNTRIES: LATERAL FLOW ASSAYS MARKET, BY END USER, 2021–2029 (USD MILLION) 320
12 COMPETITIVE LANDSCAPE 321
12.1 OVERVIEW 321
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 321
TABLE 368 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET 321
12.3 REVENUE SHARE ANALYSIS 322
FIGURE 41 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN PAST FIVE YEARS 323
12.4 MARKET SHARE ANALYSIS 323
FIGURE 42 LATERAL FLOW ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022) 324
TABLE 369 LATERAL FLOW ASSAYS MARKET: DEGREE OF COMPETITION 325
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 325
12.5.1 STARS 325
12.5.2 PERVASIVE PLAYERS 325
12.5.3 EMERGING LEADERS 326
12.5.4 PARTICIPANTS 326
FIGURE 43 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022 326
12.5.5 COMPANY FOOTPRINT 327
FIGURE 44 COMPANY FOOTPRINT (25 COMPANIES) 327
TABLE 370 PRODUCT FOOTPRINT (25 COMPANIES) 328
TABLE 371 TECHNIQUE FOOTPRINT (25 COMPANIES) 329
TABLE 372 APPLICATION FOOTPRINT (25 COMPANIES) 330
TABLE 373 SAMPLE TYPE FOOTPRINT (25 COMPANIES) 331
TABLE 374 END-USER FOOTPRINT (25 COMPANIES) 332
TABLE 375 REGIONAL FOOTPRINT (25 COMPANIES) 333
12.6 COMPANY EVALUATION MATRIX: SMES & STARTUPS 334
12.6.1 PROGRESSIVE COMPANIES 334
12.6.2 DYNAMIC COMPANIES 334
12.6.3 STARTING BLOCKS 334
12.6.4 RESPONSIVE COMPANIES 334
FIGURE 45 LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2022 335
12.6.5 COMPETITIVE BENCHMARKING 335
TABLE 376 LATERAL FLOW ASSAY MARKET: DETAILED LIST OF KEY STARTUP/SMES 335
TABLE 377 LATERAL FLOW ASSAY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES 336
12.7 COMPETITIVE SCENARIO 337
12.7.1 PRODUCT LAUNCHES & APPROVALS 337
TABLE 378 LATERAL FLOW ASSAYS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–DECEMBER 2023 337
12.7.2 DEALS 338
TABLE 379 LATERAL FLOW ASSAYS MARKET: DEALS, JANUARY 2020–DECEMBER 2023 338
12.7.3 EXPANSIONS 338
TABLE 380 LATERAL FLOW ASSAYS MARKET: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 338
12.7.4 OTHER DEVELOPMENTS 338
TABLE 381 LATERAL FLOW ASSAYS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–DECEMBER 2023 338
12.8 R&D ASSESSMENT OF KEY PLAYERS 339
FIGURE 46 R&D EXPENDITURE: MAJOR PLAYERS IN LATERAL FLOW ASSAYS MARKET, 2021 VS. 2022 339
12.9 INVESTMENT LANDSCAPE 339
FIGURE 47 LATERAL FLOW ASSAY MARKET FUNDING SOARED IN 2022 339
FIGURE 48 MOST VALUED LATERAL FLOW ASSAY FIRMS IN 2022 (USD BILLION) 340
12.10 VALUATION AND FINANCIAL MATRICES 340
FIGURE 49 LATERAL FLOW ASSAYS MARKET: VALUATION AND FINANCIAL MATRICES 340

13 COMPANY PROFILES 341
13.1 KEY PLAYERS 341
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 ABBOTT LABORATORIES 341
TABLE 382 ABBOTT LABORATORIES: COMPANY OVERVIEW 341
FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022) 342
TABLE 383 ABBOTT LABORATORIES: PRODUCTS OFFERED 342
TABLE 384 ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 346
TABLE 385 ABBOTT LABORATORIES: DEALS (JANUARY 2020–DECEMBER 2023) 346
13.1.2 F. HOFFMANN-LA ROCHE LTD. 348
TABLE 386 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 348
FIGURE 51 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022) 349
TABLE 387 F. HOFFMAN-LA ROCHE: PRODUCTS OFFERED 349
TABLE 388 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 350
TABLE 389 F. HOFFMAN-LA ROCHE: DEALS (JANUARY 2020–DECEMBER 2023) 351
TABLE 390 F. HOFFMAN-LA ROCHE: EXPANSIONS (JANUARY 2020–DECEMBER 2023) 351
13.1.3 QUIDELORTHO CORPORATION 353
TABLE 391 QUIDELORTHO CORPORATION: COMPANY OVERVIEW 353
FIGURE 52 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022) 354
TABLE 392 QUIDELORTHO CORPORATION: PRODUCTS OFFERED 354
TABLE 393 QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 355
TABLE 394 QUIDELORTHO CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 356
13.1.4 DANAHER CORPORATION 357
TABLE 395 DANAHER CORPORATION: COMPANY OVERVIEW 357
FIGURE 53 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 358
TABLE 396 DANAHER CORPORATION: PRODUCTS OFFERED 358
TABLE 397 DANAHER CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023) 359
13.1.5 SIEMENS AG 361
TABLE 398 SIEMENS AG: COMPANY OVERVIEW 361
FIGURE 54 SIEMENS AG: COMPANY SNAPSHOT (2022) 362
TABLE 399 SIEMENS AG: PRODUCTS OFFERED 362
TABLE 400 SIEMENS AG: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 364
13.1.6 BECTON, DICKINSON AND COMPANY 365
TABLE 401 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 365
FIGURE 55 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 366
TABLE 402 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 366
TABLE 403 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023) 367
TABLE 404 BECTON, DICKINSON AND COMPANY: DEALS (JANUARY 2020–DECEMBER 2023) 368
TABLE 405 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023) 368
13.1.7 BIOMÉRIEUX SA 369
TABLE 406 BIOMÉRIEUX SA: COMPANY OVERVIEW 369
FIGURE 56 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2022) 370
TABLE 407 BIOMÉRIEUX SA: PRODUCTS OFFERED 370
TABLE 408 BIOMÉRIEUX SA: DEALS (JANUARY 2020–DECEMBER 2023) 371
13.1.8 THERMO FISHER SCIENTIFIC INC. 372
TABLE 409 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 372
FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 373
TABLE 410 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 373
TABLE 411 THERMO FISHER SCIENTIFIC INC.: PRODUCT APPROVALS (JANUARY 2020–DECEMBER 2023) 375
TABLE 412 THERMO FISHER SCIENTIFIC INC.: DEALS (JANUARY 2020–DECEMBER 2023) 375
13.1.9 PERKINELMER INC. 376
TABLE 413 PERKINELMER INC.: COMPANY OVERVIEW 376
FIGURE 58 PERKINELMER INC.: COMPANY SNAPSHOT (2022) 377
TABLE 414 PERKINELMER INC.: PRODUCTS OFFERED 377
TABLE 415 PERKINELMER INC.: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023) 378
TABLE 416 PERKINELMER INC.: DEALS (JANUARY 2020–DECEMBER 2023) 379
13.1.10 QIAGEN N.V. 380
TABLE 417 QIAGEN N.V.: COMPANY OVERVIEW 380
FIGURE 59 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 381
TABLE 418 QIAGEN N.V.: PRODUCTS OFFERED 381
TABLE 419 QIAGEN N.V.: DEALS (JANUARY 2020–DECEMBER 2023) 382
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS 383
13.2.1 MERCK KGAA 383
13.2.2 HOLOGIC, INC. 383
13.2.3 ABCAM PLC 384
13.2.4 SURMODICS INC. 384
13.2.5 CHEMBIO DIAGNOSTICS, INC. (BIOSYNEX) 385
13.2.6 ORASURE TECHNOLOGIES 386
13.2.7 DCN DIAGNOSTICS 386
13.2.8 POLYSCIENCES INC. 387
13.2.9 ABINGDON HEALTH 387
13.2.10 ORANOXIS INC. 388
13.2.11 AESKU.GROUP GMBH 388
13.2.12 BIO GROUP MEDICAL SYSTEM S.R.L 389
13.2.13 PHARMACT GMBH 389
13.2.14 DIESSE DIAGNOSTICA SENESE S.P.A. 390
13.2.15 XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD. 390
14 APPENDIX 391
14.1 DISCUSSION GUIDE 391
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 396
14.3 CUSTOMIZATION OPTIONS 398
14.4 RELATED REPORTS 398
14.5 AUTHOR DETAILS 399

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のラテラルフローアッセイ（LFA）市場（～2029年）：製品別（キット、リーダー）、用途別（STI、新型コロナウィルス感染症、Hep、TB、心臓マーカー、妊娠、薬物乱用、獣医診断、食品）、サンプル別（血液、尿、唾液）、技術別（サンドイッチ、競合）、エンドユーザー別(Lateral Flow Assay Market by Product (Kit, Readers), Application (STI, Covid-19, Hep, TB, Cardiac marker, Pregnancy; Drug abuse, Vet Diaganostic, Food), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User - Global Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp